Dr. Socinski on Improvements to Immunotherapy for Lung Cancer – OncLive
OncLive |
Dr. Socinski on Improvements to Immunotherapy for Lung Cancer
OncLive Mark A. Socinski, MD, executive medical director of the Florida Hospital Cancer Institute, discusses potential improvements to immunotherapy regimens for patients with lung cancer. One of the ways immunotherapy can be improved is by the selection of … |
